- 专利标题： RADIOTHERAPEUTIC AND COMPANION IMAGING AGENTS TO TARGET MC1R
-
申请号： US17810956申请日： 2022-07-06
-
公开(公告)号： US20230211022A1公开(公告)日： 2023-07-06
- 发明人: David MORSE , Robert GILLIES , Mark MCLAUGHLIN , Thaddeus WADAS , Hyun Joo KIL , Narges TAFRESHI
- 申请人： H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. , Modulation Therapeutics, Inc. , Wake Forest University Health Sciences
- 申请人地址： US FL Tampa
- 专利权人： H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.,Modulation Therapeutics, Inc.,Wake Forest University Health Sciences
- 当前专利权人： H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC.,Modulation Therapeutics, Inc.,Wake Forest University Health Sciences
- 当前专利权人地址： US FL Tampa
- 主分类号： A61K51/08
- IPC分类号： A61K51/08 ; G01N33/574 ; C07K14/705 ; A61K38/08 ; A61P35/04 ; C07K7/06 ; A61K38/00
摘要：
The subject matter disclosed herein relates generally to cancer therapy and to anticancer compounds and imaging agents. More specifically, the subject matter disclosed herein relates to agents that target MC1R and their use in the treatment of cancer. Methods of screening for MC1R targeted agents are also disclosed.
信息查询
